Psoriasis drug may also aid weight loss
Nearly 20% of patients lost more than 5% of their baseline weight by 52 weeks or less when assigned to receive apremilast.
All articles by Cassandra A. Richards
Additional evidence of link between psoriasis, kidney disease
Patients with psoriasis should avoid long-term use of medications that are toxic to the kidneys.
Biologic therapy may be safe for hemodialysis patients with psoriasis
Patient with psoriasis were unsuccessfully treated with conventional therapies before treatment with biologics.
Psoriasis not independent risk factor for heart disease
Patients with psoriasis do not have an increased of major cardiovascular events like heart attack and stroke.
Adalimumab clears psoriasis faster than traditional treatment
Patients taking adalimumab saw quicker treatment of their psoriasis than those taking methotrexate.
Possible link between male sex hormones, psoriasis severity
Male patients with psoriasis have higher levels of estradiol and lower levels of testosterone compared with controls.
Phase 1 trial results favorable for new psoriasis drug
The rate of reported adverse events was comparable in both the treatment and placebo groups.
Therapeutic silencing of IL-23 may treat psoriasis
These study findings confirm that the therapeutic silencing of IL-23 is a potential target for psoriasis prevention and management.
Sleep apnea could raise psoriasis risk in women
The presence of snoring was not associated with a higher risk of psoriasis.
Researchers identify gene that causes psoriatic arthritis
This discovery could prevent progression of psoriatic arthritis in patients with psoriasis.
Next post in Psoriasis Information Center
